Operational Handbooks

This checklist is based on one produced by Médecins Sans Frontières (1).

Instructions: This tool provides an idea of the risk of transmission of M. tuberculosis in a health-care facility or congregate setting. The results should be completed by the IPC focal person and interpreted by the IPC committee. For the Yes/No questions, a Yes answer indicates good TB IPC practices. Any pertinent information on No answers is noted in the Comments section below each table.

                                                               TB epidemiological surveillance form

Continued monitoring of collaborative TB/DM activities and evaluation of their impact is critical for scaling up, for monitoring progress and for identifying gaps in implementation. This requires an effective, efficient monitoring and evaluation system. Table A.4.1. summarizes suggested core indicators for monitoring and evaluating collaborative TB/DM activities.
 

Table A.4.1. Summary of indicators for monitoring and evaluating collaborative TB/DM activities

Urgent (same day) referral should be assured if one of the following is detected:

• urine ketones ≥ 2 or no improvement in glycaemia ≥ 18 mmol/L after management with metformin and/or gliclazide;
• suspicion of ketoacidosis or hyperosmolar hyperglycaemic state;
• hypoglycaemia unresolved by treatment;
• clinical suspicion of type 1 diabetes in a newly diagnosed patient;
• symptoms or signs of coronary heart disease and stroke;
• recent deterioration of vision;
• blood pressure > 200/> 110 mm Hg
• blood pressure >

Screening people with diabetes for TB

Evidence reviewers

Kenneth G Castro declared receiving ongoing funding from USAID to serve as Senior TB Scientific Advisor (80% level of effort), from the National Institutes of Health to serve as Associate Director Emory-Georgia TB Research Advancement Center (10% level of effort), and from the US Department of State, Bureau of Education and Cultural Affairs, to serve as Coordinator of the Emory Hubert H. Humphrey Fellowship Program (10% level of effort).

All reference accessed 11 September 2024

4.2.1 Management of type 2 diabetes

WHO recommends biochemical testing for diabetes among adults who have signs and symptoms of diabetes, among adults who are ≥ 40 years with a BMI > 25 kg/m² or anyone with a BMI > 30 kg/m² (33,34). WHO also recommends that individuals with TB be screened for diabetes (21).